A joint One Nucleus and Cerba Research Innovation Seminar across two days focussing on exciting developments for therapeutics in two key research areas – metabolic disease and infectious disease.

Agenda

Day 1 Metabolic Disease

3:00 pm Welcome

3:10 pm Detection and diagnosis of metabolic disease
Dr Pablo Ortiz, CSO, OWL Metabolomics
Role of metabolomics in drug development of metabolic diseases

Dr Huw Davies, VP of Global Sales, Owlstone Medical

4:00 pm Break

4:15 pm Innovative therapeutic approaches to metabolic disease
Dr David Blakey, CSO, MiNA Therapeutics
Second presentation tbc

5:05 pm Dr Graham Wylie, CEO, Medical Research Network, Decentralised clinical trials – improving patient engagement and trial efficiency

5:30 pm Finish

 

Day 2 Infectious Disease

2:00 pm Welcome back

2:10 pm Becky Jones-Philips, Business Development Manager, Liverpool School of Tropical Medicine, Delivering Integrated Solutions for Human Infections

2:35 pm Cerba Research, Challenges of Covid-19 testing- which test to use?, Speaker tbc

3:00 pm Break

3:15 pm Treatment and prevention of serious infectious disease
Valneva, Speaker tbc

Dr Stephane Renard, Global Project Leader, Antibacterials, Evotec
From an antibacterial into a novel therapeutic solution: bottlenecks and strategies

4:05 pm Networking

5:00 pm Finish

Register here

Add to Calendar

Back to Events

Schedule a Meeting